-
Security Type
-
Equity
-
Categories
-
Other
-
Min Investment
-
$101
-
Offering Date
-
February 27, 2020
-
Expected Close Date
-
August 28, 2020
-
Target Raise
-
$10.00K-$1.07M
-
Deal Notes
-
Security Name: Common Stock
$1.04 per share
-
Valuation
-
$10,000,000
Company Description
We provide a platform and service that enables individuals to order restorative infusion/IV treatments on demand to their location. Reset IV supports recovery from common conditions like migraines, food poisoning, and hangovers. Reset IV also provides nutritional boosts for relaxation and sexual health as well as immune boosts for wellness. We offer beauty solutions and support through specific blends of nutrients tailored for our clientele which includes people from all socioeconomic status and professions. Our services, provided in the comfort of your home, allow customers to bypass the lines that plague emergency rooms and and avoid the crowds in wellness clinics. We believe in simple, convenient, and comfortable healthcare.
Key Deal Facts
Over 3.7M in revenue in under 2 years combined from the company and its newly acquired subsidiaries.
We operate in the national telemedicine market, which is is anticipated to be valued at over $43.37 Billion by 2025, with a CAGR of 19.90% per year between now and 2026. (Marketwatch)
Now entering our third year of operations, we boasted a 84.51% increase in sales from 2018 to 2019.
Use of Proceeds
Marketing, Research & Development, Operations, Inventory, Working Capital, Company Employment, StartEngine Platform Fes
Management Team / Advisory Board Bios
Daniel Rubenstein
CEO
As coo of an International sourcing business he multiplied the company's revenue by 150%year over year for 3 consecutive years and improved the company’s profit margin by 50%. Daniel is a father of3 and a leader in his community. Daniel is an ordained Rabbi and a former volunteer EMT for an ambulance company. Daniel started Reset IV and, together with his tea,m took it from an idea to $3.5 million sales and over 11,000 clients in 2 years by bootstrapping with only $70,000 of his own money. Daniel is passionate about making healthcare and wellness treatments more accessible and comfortable for people. Daniel currently still acts as coo of Prestige Sourcing Group, the international sourcing company. In addition, Daniel still gives Jewish education classes in his community. Daniel's primary role is with Reset IV where he spends over 1ohours a day on the company.
Lori Parks
Controller/Treasurer
Lori graduated from UNLV with a Bachelors in Business Administration with a Major in Accounting. Lori went on to work for U-Swirl helping to take them from a small, one store “mom and pop” shop, to a buyout by Healthy Fast Food Inc (OTCBB:HFFIW) including preparing their financials for 10K/10Q requirements. Lori has a scary love for numbers and an incredible dedication for detail.
Dr. David Sherman
Medical Advisor
Dr. David Sherman is a Board Certified Internist who has been practicing Internal Medicine and Nephrology in Glendale California since 1981. Additionally, he has held the position of Medical Director of Care Coordination at Glendale Memorial Hospital, a Dignity Health facility, for more than 2 decades. Dr. Sherman joined Reset IV in 2019 as an additional demonstration of his pursuit of providing the highest quality health care and service. He and Reset IV share the same passion for excellence.
Elisheva Rubenstein
Secretary
Elisheva is currently the CEO of Prestige Sourcing Group, an international sourcing company that helps Fortune 500 companies design and manufacture various categories of packaging.
In addition, Elisheva works per-diem as a Radiologic Technologist at SDMI in Las Vegas.
These two roles are her primary roles. She only spends about 1 hour per week with Reset IV
Deal Notes
Security Name: Common Stock
$1.04 per share